What to watch with Pharmakogenetik Medicheck and Blutzucker?

When combining pharmacogenetics (e.g., Medicheck) with blood sugar monitoring, several points deserve attention. Pharmacogenetic tests analyze genes involved in drug metabolism and response – such as CYP2C9, CYP2C19, or SLCO1B1. Some of these genes also influence glucose metabolism, but the evidence for direct clinical action based solely on such tests is often limited. Blood sugar is regulated by diet, exercise, medications, and hormones; a genetic test alone cannot reliably predict glucose spikes or diabetes risk. Be aware that direct-to-consumer tests may not be clinically validated. Always consult a physician or pharmacist before adjusting medication or diet based on genetic variants. For diabetes drugs like metformin or sulfonylureas, certain variants can affect efficacy and side effects, but the effect sizes are modest. In summary: pharmacogenetics can offer clues, but it does not replace medical supervision. Blood sugar values must always be interpreted in a broader clinical context.